# EDGAR Filing Document

**Accession Number:** 0001857410
**File Stem:** 0001193125-23-062051
**Filing Date:** 2023-3
**Character Count:** 29781
**Document Hash:** 60e2bd5657d779e17d0a5b964480a0b8
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-062051.hdr.sgml**: 20230307

**ACCESSION NUMBER**: 0001193125-23-062051

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20230307

**ITEM INFORMATION**: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

**ITEM INFORMATION**: Other Events

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230307

**DATE AS OF CHANGE**: 20230307

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Investcorp Europe Acquisition Corp I
- **CENTRAL INDEX KEY:** 0001857410
- **STANDARD INDUSTRIAL CLASSIFICATION:** BLANK CHECKS [6770]
- **IRS NUMBER:** 000000000
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41161
- **FILM NUMBER:** 23710993

**BUSINESS ADDRESS:**
- **STREET 1:** C/O PAGET-BROWN TRUST COMPANY LTD.
- **STREET 2:** CENTURY YARD, CRICKET SQ., P.O. BOX 1111
- **CITY:** GEORGE TOWN
- **STATE:** E9
- **ZIP:** KY1-1102
- **BUSINESS PHONE:** 1 345 949 5122

**MAIL ADDRESS:**
- **STREET 1:** C/O PAGET-BROWN TRUST COMPANY LTD.
- **STREET 2:** CENTURY YARD, CRICKET SQ., P.O. BOX 1111
- **CITY:** GEORGE TOWN
- **STATE:** E9
- **ZIP:** KY1-1102

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Investcorp Asia Acquisition Corp I
- **DATE OF NAME CHANGE:** 20210416

?xml version="1.0" encoding="utf-8" ? 8-K

------

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION

#### Washington, D.C. 20549

------

### FORM 8-K

------

#### CURRENT REPORT

#### PURSUANT TO SECTION 13 OR 15(D)

#### OF THE SECURITIES EXCHANGE ACT OF 1934

#### Date of Report (Date of earliest event reported): March 7, 2023

------

## Investcorp Europe Acquisition Corp I

#### (Exact name of registrant as specified in its charter)

------

---

| | | |
|:---|:---|:---|
| **Cayman Islands** | **001-41161** | **N/A** |
| **(State or other jurisdiction**<br> **of incorporation)** | **(Commission**<br> **File Number)** | **(I.R.S. Employer**<br> **Identification No.)** |

---

---

| | |
|:---|:---|
| **Century Yard, Cricket Square** |  |
| **Elgin Avenue** |  |
| **P.O. Box 1111, George Town** |  |
| **Grand Cayman, Cayman Islands** | **KY1-1102** |
| **(Address of principal executive offices)** | **(Zip Code)** |

---

#### +1 (345) 949-5122

#### (Registrant's telephone number, including area code)

#### Not Applicable

#### (Former name or former address, if changed since last report)

------

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading<br>Symbol(s)** | **Name of each exchange**<br> **on which registered** |
| Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant | IVCBU | The Nasdaq Stock Market LLC |
| Class A ordinary shares, par value $0.0001 per share | IVCB | The Nasdaq Stock Market LLC |
| Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 | IVCBW | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

---

| | |
|:---|:---|
| **Item 2.03** | **Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant** |

---

On March 7, 2023, Investcorp Europe Acquisition Corp I (the "Company") entered into a non-interest bearing convertible unsecured loan (the "Loan") in the principal amount of up to $2,000,000 from the Company's sponsor, Europe Acquisition Holdings Limited, an exempted company incorporated in the Cayman Islands, or an affiliate thereof (the "Sponsor") to provide the Company with additional working capital during the proposed Extension (as defined below), and to fund the initial Contributions described in Item 8.01. The portion of the Loan used to provide the Company with additional working capital during the Extension will not be deposited into the Company's trust account (the "Trust Account").

If the Company does not consummate an initial business combination by the Extended Date (as defined below), the Loan will be repaid only from funds held outside of the Trust Account or will be forfeited, eliminated or otherwise forgiven. The Contributions are conditioned on the approval of the Extension Amendment Proposal (as defined below) and the implementation of the Extension. If at any time following the Extraordinary General Meeting (as defined below), the Company's board of directors (the "Board") determines that the Company will not be able to consummate an initial business combination by the Extended Date and that the Company shall instead liquidate, the Sponsor's obligation to continue to make Contributions shall cease immediately upon such determination.

A copy of the Loan is attached as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference. The disclosure as set forth in this Item 2.03 is intended to be a summary only and is qualified in its entirety by reference to the Loan.

---

| | |
|:---|:---|
| **Item 8.01** | **Other Events** |

---

While the Company is currently in discussions regarding business combination opportunities and has signed a non-binding letter of intent with a target, the Board has determined that there may not be sufficient time before March 17, 2023 to consummate an initial business combination. Therefore, the Board has determined the Extension Amendment Proposal is in the best interests of the Company's shareholders.

------

If the Extension Amendment Proposal is approved at the Company's Extraordinary General Meeting, the Sponsor has agreed, by making monthly advancements on the Loan, to contribute (each such contribution, a "Contribution") into the Trust Account the lesser of (x) an aggregate of $350,000 or (y) $0.03 per share for each Class A ordinary share included as part of the units sold in the Company's initial public offering (including any shares issued in exchange thereof) that are not redeemed at the Extraordinary General Meeting for each monthly period (commencing on March 17, 2023 and ending on the 17<sup>th</sup> day of each subsequent month), or portion thereof, until the earlier of the completion of the initial business combination and the Extended Date. For the avoidance of doubt, the maximum aggregate Contributions to the Trust Account shall not exceed $3,150,000 based on up to nine monthly Contributions through the Extended Date. The funds in the Trust Account will remain invested in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds investing solely in U.S. government treasury obligations.

#### Supplement to the Definitive Proxy Statement
As previously announced, the Company will hold an extraordinary general meeting (the "Extraordinary General Meeting") on March 14, 2023, to consider and vote upon, among other things, a proposal (the "Extension Amendment Proposal") to extend the date by which the Company must complete a business combination from March 17, 2023 (which is 15 months from the closing date of the Company's initial public offering) to December 17, 2023 (such date, the "Extended Date"). The Company has determined to supplement the Company's definitive proxy statement related to the Extraordinary General Meeting as set forth below (the "Proxy Supplement") to provide information about the letter of intent and the proposed Contributions and to update the information provided regarding the Sponsor's right to extend the time to consummate a business combination.

There is no change to the location, the record date, or any of the proposals to be acted upon at the Extraordinary General Meeting.

#### SUPPLEMENT TO PROXY STATEMENT

#### OF

#### INVESTCORP EUROPE ACQUISITION CORP I

#### Dated March 7, 2023
*The following disclosures in this Current Report on Form 8-K supplement, and should be read in conjunction with, the disclosures contained in the Company's definitive proxy statement (the "Definitive Proxy Statement"), filed with the Securities and Exchange Commission (the "SEC") on February 28, 2023, which should be read in its entirety. To the extent the information set forth herein differs from or updates information contained in the Definitive Proxy Statement, the information set forth herein shall supersede or supplement the information in the Definitive Proxy Statement. All other information in the Definitive Proxy Statement remains unchanged.* 

*As provided in the Definitive Proxy Statement, the Company is seeking shareholder approval of, among other things, the extension (the "Extension" and such proposal, the "Extension Amendment Proposal") of the time period during which the Company has to complete an initial business combination from March 17, 2023 to December 17, 2023 (such date, the "Extended Date") and a proposal to remove from the Company's Amended and Restated Memorandum and Articles of Association ("the Articles") the limitation that the Company shall not redeem Class A ordinary shares included as part of the units sold in its initial public offering (including any shares issued in exchange thereof, the "public shares") to the extent that such redemption would cause the Company's net tangible assets to be less than $5,000,001. The purpose of the supplemental disclosures is to provide an update on the Company's discussions with a counterparty to a potential business combination and the proposed contributions to the Company's trust account in connection with the Extension.* 

*Terms used herein, unless otherwise defined, have the meanings set forth in the Definitive Proxy Statement.* 

------

#### Extension Option
The purpose of the Extension Amendment is to allow us more time to enter into and consummate a business combination. The Articles currently provide that we have until March 17, 2023 to consummate our initial business combination (the "Combination Period"). Europe Acquisition Holdings Limited, an exempted company incorporated in the Cayman Islands, or an affiliate thereof (the "Sponsor") has the right to extend the Combination Period by three months by paying an additional $3,450,000 into the Trust Account (an "Extension Option"). Our Sponsor may exercise the Extension Option twice, allowing for up to an additional six months (for a total of 21 months) to complete a business combination. Our Sponsor currently has no intention of exercising an Extension Option. If the Extension Amendment Proposal is approved, the Extension Option will be eliminated.

#### Letter of Intent
While the Company is currently in discussions regarding business combination opportunities and has signed a non-binding letter of intent with a target, the board has determined that there may not be sufficient time before March 17, 2023 to consummate an initial business combination. Therefore, the Company's board of directors has determined the Extension Amendment Proposal is in the best interests of the Company's shareholders.

#### Contributions to Trust Account
On March 7, 2023, the Company entered into a non-interest bearing convertible unsecured loan (the "Loan") in the principal amount of up to $2,000,000 from the Sponsor to provide the Company with additional working capital during the proposed Extension, and to fund the initial Contributions described herein. If the Extension Amendment Proposal is approved at the Extraordinary General Meeting, the Sponsor has agreed, by making monthly advancements on the Loan, to contribute (each such contribution, a "Contribution") into the Company's Trust Account the lesser of (x) an aggregate of $350,000 or (y) $0.03 per share for each of the public shares that are not redeemed at the Extraordinary General Meeting for each monthly period (commencing on March 17, 2023 and ending on the 17<sup>th</sup> day of each subsequent month), or portion thereof, until the earlier of the completion of the initial business combination and the Extended Date. For the avoidance of doubt, the maximum aggregate Contributions to the Trust Account shall not exceed $3,150,000 based on up to nine monthly Contributions through the Extended Date. The funds in the Trust Account will remain invested in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds investing solely in U.S. government treasury obligations.

The portion of the Loan used to provide the Company with additional working capital during the Extension will not be deposited into the Trust Account.

If the Company does not consummate an initial business combination by the Extended Date, the Loan will be repaid only from funds held outside of the Trust Account or will be forfeited, eliminated or otherwise forgiven. The Contributions are conditioned on the approval of the Extension Amendment Proposal and the implementation of the Extension. If at any time following the Extraordinary General Meeting, the Board determines that the Company will not be able to consummate an initial business combination by the Extended Date and that the Company shall instead liquidate, the Sponsor's obligation to continue to make Contributions shall cease immediately upon such determination.

#### Forward-Looking Statements
This communication includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally relate to future events or the Company's future financial or operating performance. Certain of these forward-looking statements can be identified by the use of words such as "believes," "expects," "intends," "plans," "estimates," "assumes," "may," "should," "will," "would," "seem," "anticipates," "seeks," "future," "predicts," "potential" or "continue" or the negatives of these terms or variations of them or similar terminology, but the absence of these words does not mean that a statement is not forward-looking. Such statements may include, but are not limited to, statements regarding the proposed Contributions. These statements are based on current expectations on the date of this announcement and involve a number of risks and uncertainties that may cause actual results to differ significantly. Many actual events and circumstances are beyond the control of the Company. These forward looking statements are subject to a number of risks and uncertainties, including: the Company's ability to enter into definitive agreements or consummate a transaction with an initial business combination target; the amount of

------

redemption requests made by the Company's shareholders and the amount of funds remaining in the Trust Account after satisfaction of such requests; and those factors discussed in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2021 under the heading "Risk Factors," and other documents of the Company filed, or to be filed, with the SEC. If the risks materialize or assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that the Company presently does not know or that the Company currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect the Company's expectations, plans or forecasts of future events and views as of the date hereof. The Company anticipates that subsequent events and developments will cause the Company's assessments to change. The Company does not assume any obligation to update or revise any such forward-looking statements, whether as the result of new developments or otherwise. These forward-looking statements should not be relied upon as representing the Company's assessments as of any date subsequent to the date of this current report. Readers are cautioned not to put undue reliance on forward-looking statements.

#### Additional Information and Where to Find It
On February 28, 2023, the Company filed the Definitive Proxy Statement with the SEC in connection with its solicitation of proxies for the Extraordinary General Meeting. INVESTORS AND SECURITY HOLDERS OF THE COMPANY ARE URGED TO READ THE DEFINITIVE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND OTHER DOCUMENTS THE COMPANY FILES WITH THE SEC CAREFULLY IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE AS THEY WILL CONTAIN IMPORTANT INFORMATION. Investors and security holders will be able to obtain free copies of the Definitive Proxy Statement (including any amendments or supplements thereto) and other documents filed with the SEC through the web site maintained by the SEC at www.sec.gov or by directing a request to: Investcorp Europe Acquisition Corp I, Century Yard, Cricket Square, Elgin Avenue, P.O. Box 1111, George Town, Grand Cayman KY1-1102, Cayman Islands.

#### Participants in the Solicitation
The Company and its respective directors and officers may be deemed to be participants in the solicitation of proxies from shareholders in connection with the Extraordinary General Meeting. Additional information regarding the identity of these potential participants and their direct or indirect interests, by security holdings or otherwise, is set forth in the Definitive Proxy Statement. You may obtain free copies of these documents using the sources indicated above.

---

| | |
|:---|:---|
| **Item 9.01** | **Financial Statements and Exhibits.** |

---

(d) Exhibits. The following exhibits are filed with this Form 8-K:

---

| | |
|:---|:---|
| Exhibit No. | Description of Exhibits |
| 10.1 | [Loan Agreement dated March 7, 2023.](d479184dex101.htm) |
| 104 | Cover Page Interactive Data File (embedded within the inline XBRL Document). |

---

------

#### SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | Investcorp Europe Acquisition Corp I | Investcorp Europe Acquisition Corp I |
| Date: March 7, 2023 | By: | /s/ Craig Sinfield-Hain |
|  | Name: | Craig Sinfield-Hain |
|  | Title: | Chief Financial Officer |

---

## Exhibit 10.1

**Exhibit 10.1** 

**<u>LOAN AGREEMENT</u>**

This Loan Agreement (this "**Agreement**") is made on this day of March 7, 2023 (the "**Effective Date**").

BETWEEN:

1. **Investcorp Europe Acquisition Corp I**, an exempted company incorporated under the laws of
the Cayman Islands with registration number 373300 (the "**Borrower** ");

2. **Investcorp Funding Limited**, an exempt company incorporated under the laws of the Cayman Islands with
registration number 25543 (the "**Lender** ").

WHEREAS:

A. The Borrower wishes to borrow money to fund working capital ("Working Capital") and contributions
("Contributions") in connection with any extension of the date (the "Extension") by which the Borrower consummates its initial business combination (the "**Transaction**);

B. The Lender has agreed to provide a convertible loan to the Borrower to be used by the Borrower to fund the
Transaction.

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows with effect from the Effective Date:

**1.**  **<u>Recitals Integral</u>** 

The recitals above shall form an integral part of this Agreement.

**2.**  **<u>Amount and Purpose of Loan</u>** 

2.1 The Lender hereby agrees to lend to the Borrower a loan in a maximum aggregate amount of Two Million Dollars
($2,000,000.00) in lawful money of the United States of America (the "**Loan** ").

2.2 The Lender shall make the Loan available to the Borrower on the Effective Date of March 7, 2023. The Borrower
may draw the Loan in one or more drawdowns upon prior written notice to the Lender and the Lender agrees in advance to fund the Contributions directly into the Borrower's trust account (the "Trust Account") established in connection
with Borrower's initial public offering. The Lender's obligation to fund Contributions into the Trust Account shall terminate upon the earlier of
(i) December 17, 2023 (the "Extended Date"), (ii) the closing of an initial business combination and (iii) such date
as the Lender determines that no initial business combination will be entered into prior to the Extended Date.

------

2.3 Subject to the terms of this Agreement, the Lender will be obliged to fund the Loan in any amount which is
required by the Borrower to fund the Working Capital and Contributions and the Lender shall not be entitled to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) cancel any commitments under this Agreement to the extent to do so would prevent or limit the funding of the
Working Capital and Contributions ;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) rescind, terminate or cancel this Agreement or the Loan or exercise any similar right or remedy or make or
enforce any claim under this Agreement it may have to the extent to do so would prevent or limit the funding of the Working Capital and Contributions ;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) refuse to participate in any advance requested by the Borrower in accordance with this Agreement to fund the
Working Capital and Contributions ;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) exercise any right of set-off or counterclaim in respect of the Loan to
the extent to do so would prevent or limit the funding of the Working Capital and Contributions ; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) cancel, accelerate or cause repayment or prepayment of any amounts owing under this Agreement to the extent to
do so would prevent or limit the funding of the Working Capital and Contributions ,

provided that immediately upon completion of the Transaction all such rights, remedies and entitlements shall be available to the Lender.

2.4 The Borrower shall use the Loan to fund the Working Capital and
Contributions .

**3.**  **<u>Interest on the Loan</u>** 

No interest shall accrue on the unpaid balance of the Loan.

**4.**  **<u>Optional Conversion</u>** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Upon consummation of the business combination and at the Lender's option, at any time prior to payment in full of the principal balance of this Loan, the Lender may elect to convert all or any portion of the Loan into that number of warrants (the "New Units") equal to: (i) the portion of the principal amount of the Loan being converted pursuant to this Section 4, divided by (ii) $1.00, rounded down to the nearest whole number. Each New Unit shall have the same terms and conditions as private placement warrants issued simultaneously with the Borrower's initial public offering.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Upon any complete or partial conversion of the principal amount of this Loan (i) such principal amount shall be so converted and such converted portion of this Loan shall become fully paid and satisfied, (ii) in exchange for all or any portion of the surrendered Loan described in Section 4(a), Borrower shall deliver to Lender the New Units, which shall bear such legends as are required, in the opinion of counsel to Borrower or by any other agreement between Borrower and the Lender and applicable state and federal securities laws.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) The Borrower shall pay any and all issue and other taxes that may be payable with respect to any issue or delivery of the New Units upon conversion of this Loan pursuant hereto; provided, however, that the Lender shall pay any transfer taxes resulting from any transfer requested by the Lender in connection with any such conversion.

**5.**  **<u>Repayment of the Loan</u>** 

5.1 The Borrower shall repay the principal amount of the Loan on the earlier of: (i) the date on which the
Borrower consummates the Transaction or (ii) the date of that the winding up of the Borrower is effective (such date, the "**Maturity Date** ").

5.2 The Borrower may prepay the Loan, in whole or in part, at any time without penalty.

5.3 All payments made by the Borrower to the Lender under this Agreement shall be made in immediately available
funds and shall be paid by transfer to such bank account of the Lender as the Lender shall notify to the Borrower in writing.

5.4 Under no circumstances shall any individual, including but not limited to any executive officer, director,
employee or stockholder of the Borrower, be obligated personally for any obligations or liabilities of the Borrower hereunder.

**6.**  **<u>Statements Conclusive</u>** 

The statement of the Lender as to any amount payable by the Borrower hereunder shall (in the absence of obvious error) be conclusive and binding on the parties hereto.

**7.**  **<u>Waiver; Amendments</u>** 

No failure on the part of the Lender to exercise, or delay in exercising, any right shall operate as a waiver thereof, and no specific waiver shall be construed as a general waiver. Any amendment hereto or waiver of any provision hereof may be made with, and only with, the written consent of the Borrower and the Lender.

**8.**  **<u>Severability</u>** 

If any provision hereof shall be illegal or unenforceable for any reason, the legality and enforceability of the remainder of the provisions hereof shall not be affected or impaired thereby.

**9.**  **<u>Entire Agreement</u>** 

This Agreement constitutes the entire agreement between the parties to this Agreement in relation to the Loan, the Lender's obligation to make or fund the Loan and the Borrower's obligations in respect of the Loan, and supersedes any previous agreement, whether express or implied, regarding the Loan.

------

**10.**  **<u>Notices</u>** 

All notices to be given under this Agreement shall be in writing and shall be served to the addresses stated below or to such other address as a party may subsequently designate in writing to the other parties. Alternatively, notices may be served by e-mail.

If to the Borrower, to:

Century Yard, Cricket Square

Elgin Avenue

P.O. Box 1111

George Town, Grand Cayman

Cayman Islands KY1-1102

If to the Lender, to:

c/o Investcorp Holdings B.S.C.

P.O. Box 5340

Manama

Bahrain

Attention: Mr. Abbas Rizvi

**11.**  **<u>Assignment</u>** 

11.1 This Agreement shall benefit and be binding upon the parties hereto and their respective successors and
permitted assigns or transferees. Any reference in this Agreement to any party shall be construed accordingly.

11.2 The Lender shall not, at any time prior to completion of the Transaction, assign, transfer or otherwise dispose
of all or any of its rights or obligations under this Agreement without the prior written consent of the Borrower.

11.2 The Borrower shall not assign, transfer or otherwise dispose of all or any of its rights or obligations under
this Agreement without the prior written consent of the Lender.

**12.**  **<u>Trust Waiver</u>** 

Notwithstanding anything herein to the contrary, the Lender hereby waives any and all right, title, interest or claim of any kind ("Claim") in or to any distribution of or from the Trust Account, and hereby agrees not to seek recourse, reimbursement, payment or satisfaction for any Claim against the Trust Account for any reason whatsoever; provided however that upon the consummation of the initial business combination, Borrower shall repay the principal balance of this Note out of the proceeds released to Borrower from the Trust Account.

------

**13.**  **<u>Governing Law and Jurisdiction</u>** 

(a) This Agreement shall be governed and construed in all respects in accordance with the laws of the Cayman
Islands.

(b) The Borrower hereby irrevocably submits to the non-exclusive jurisdiction of the Courts of the Cayman Islands, with the Lender reserving its rights to instigate legal proceedings in any other country where it may deem it relevant to do so in order to protect its interests.

------

SIGNED on behalf of the parties hereto on the day and year first above written.

---

| | |
|:---|:---|
| Borrower | The Lender |
| /s/ Peter McKellar | /s/ Dean Clinton |
| **Investcorp Europe Acquisition Corp I** | **Investcorp Funding Limited** |
| Name: Peter McKellar | Name: Dean Clinton |
| Title: Director | Title: Director |

---